This is a new symposium at NACFC. The goal of this session is to review important publications over the last 2 years. The audience for this session is the entire cystic fibrosis team and the focus of the presentations will be on providing information in a way to help a patient that a member of the audience may see in clinic or the hospital after NACFC. The four topics will be presented by international experts in the field. Recent publications will be discussed for each topic: 1) Challenges in the diagnosis of CF infants following newborn screening; 2) Pulmonary exacerbation's and what we have learned from the STOP studies; 3) Mental health in CF and 4) an update on CFTR modulators. Attendees will be provided with a publication list for each of the topics.
Summarize an approach to the challenge in cystic fibrosis infants with inconclusive diagnosis following newborn screening.
Describe the up to date approach to pulmonary exacerbations and for CFTR modulators.
Assess the current literature regarding mental heath in cystic fibrosis.